No abstract available
MeSH terms
-
Anticoagulants / pharmacology*
-
Aryl Hydrocarbon Hydroxylases / genetics
-
Cost-Benefit Analysis*
-
Cytochrome P-450 CYP2C9
-
Humans
-
Mixed Function Oxygenases / genetics
-
Pharmacogenetics / economics*
-
Vitamin K Epoxide Reductases
-
Warfarin / pharmacology*
Substances
-
Anticoagulants
-
Warfarin
-
Mixed Function Oxygenases
-
CYP2C9 protein, human
-
Cytochrome P-450 CYP2C9
-
Aryl Hydrocarbon Hydroxylases
-
Vitamin K Epoxide Reductases